About
Technology
Issues
FAQ
Links
Official Page
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
